Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.49NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.67NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.190NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.120NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AM.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AA.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.249NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AA.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.505NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.406NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.115NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.29NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AA.8NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.12NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.75.3 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BF.35NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
CY.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FR.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBJ.4NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
CP.7NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
GJ.1.2.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
CK.1.1.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.2.56.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BF.7.21NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BF.7.13.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BF.37NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
CK.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
CM.5NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBC.1.3.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
JN.11.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XDLNChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
JN.17NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.29.1 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BC.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.2.10.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.2.3.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.2.3.13NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.2.3.9NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.2.10.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.2.56NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.2.29NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.2.10NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BY.1.1.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
DK.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BQ.1.11.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.5.2.63NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FM.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
GA.4.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
GK.1.10.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
EG.10NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used